Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Supply of Biodistribution & Single Dose Toxicity Studies of Antibodies & ADCs

  • First published: 26 August 2021
  • Last modified: 26 August 2021

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-kuma6s-106205
Published by:
Swansea University
Authority ID:
AA0345
Publication date:
26 August 2021
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6m project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is aimed at developing new therapeutics for the treatment of ovarian cancer. A key output of the CEAT project is to establish a developmental pipeline for clinically acceptable monovalent ADCs (Antibody Drug Conjugates). As part of the project, 1 ADC has been developed and is ready, whilst a further 2 are currently under development and will be ready for follow up later next year. This procurement therefore covers the requirement for all 3 ADCs to undergo in-vivo tissue distribution and toxicology studies, in order to understand the suitability of these drugs in an in-vivo setting. This service is to be carried out at the supplier organisation, and resulting products and research outputs are to be received by the RBGO group at Swansea University Singleton Campus. Due to the sensitive nature of the project is essential that this contract be awarded to a single supplier and not split across a number of suppliers.

Full notice text

CONTRACT AWARD NOTICE – NATIONAL

SERVICES

1 Authority Details

1.1

Authority Name and Address


Swansea University

Procurement , Swansea University, Singleton Park,

Swansea

SA2 8PP

UK

Sue Davies

+44 1792295890


www.swansea.ac.uk

2 Contract Details

2.1

Title

Supply of Biodistribution & Single Dose Toxicity Studies of Antibodies & ADCs

2.2

Description of the contract

The Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6m project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is aimed at developing new therapeutics for the treatment of ovarian cancer.

A key output of the CEAT project is to establish a developmental pipeline for clinically acceptable monovalent ADCs (Antibody Drug Conjugates). As part of the project, 1 ADC has been developed and is ready, whilst a further 2 are currently under development and will be ready for follow up later next year. This procurement therefore covers the requirement for all 3 ADCs to undergo in-vivo tissue distribution and toxicology studies, in order to understand the suitability of these drugs in an in-vivo setting.

This service is to be carried out at the supplier organisation, and resulting products and research outputs are to be received by the RBGO group at Swansea University Singleton Campus.

Due to the sensitive nature of the project is essential that this contract be awarded to a single supplier and not split across a number of suppliers.

2.3

Notice Coding and Classification

71900000 Laboratory services
73100000 Research and experimental development services
1018 Swansea

2.4

Estimated Total Value

3 Procedure

3.1

Type of Procedure

Single stage

4 Award of Contract

4.1

Successful Bidders

4.1.1

Name and Address of successful supplier, contractor or service provider





Axis Bioservices

189 Castleroe Road, Coleraine,

Londonderry

BT51 3RP

UK




5 Other Information

5.1

Reference number attributed to the notice by the contracting authority

SU21(21)

5.2

Date of Contract Award

 01-02-2021

5.3

Number of tenders received

1

5.4

Other Information

(WA Ref:113556)

Relates to the following project/programme financed by EU Community Funds: Welsh Government (WEFO) and Smart Expertise

5.5

Additional Documentation

N/a

5.6

Publication date of this notice:

 26-08-2021

Coding

Commodity categories

ID Title Parent category
71900000 Laboratory services Architectural, construction, engineering and inspection services
73100000 Research and experimental development services Research and development services and related consultancy services

Delivery locations

ID Description
1018 Swansea

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

Document family

Notice details
Publication date:
02 December 2020
Deadline date:
21 December 2020 00:00
Notice type:
Contract Notice
Authority name:
Swansea University
Publication date:
26 August 2021
Notice type:
Contract Award Notice
Authority name:
Swansea University

About the buyer

Main contact:
N/a
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.